4 results
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
the mainstay of VTE ... . heparin, LMWH, ... anticoagulant (e.g ... #LMWH #UFH #DOAC ... #Fondaparinux #NOAC
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
anticoagulants (DOACs ... anticoagulant; LMWH ... molecular weight heparin ... body mass index; VTE ... #DOAC #VTE #Malignancy
Summary of Coagulation Deficiencies
Inherited:
 • Hemophilia A - Deficiency of Factor VIII
 • Hemophilia B -
of Coagulation Deficiencies ... Medications - Heparin ... , LMWH, warfarin ... , DOACs (e.g. direct ... #Coagulation #Deficiencies
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
algorithm for VTE ... risk of recurrent VTE ... DOAC, direct oral ... low-molecular-weight heparin ... #DOAC #VTE #Malignancy